Drug General Information
Drug ID
D0R4UW
Former ID
DCL000964
Drug Name
Roflumilast
Synonyms
DAXAS; ROF; Roflumilast [USAN]; BY217; BYK20869; APTA-2217; BY-217; Roflumilast (JAN/USAN/INN); 3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-(DIFLUOROMETHOXY)BENZAMIDE; 3-Cyclopropylmethoxy-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide; 3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-di-chloropyrid-4-yl)benzamide
Drug Type
Small molecular drug
Indication Asthma [ICD10:J45] Approved [531783], [541997]
Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10:J40-J44, J47] Withdrawn from market [537075], [541997]
Atopic dermatitis [ICD9: 691.8, 692.9; ICD10:L00-L99] Discontinued in Phase 2 [537075], [541997]
Company
Nycomed US Inc; Altana
Structure
Download
2D MOL

3D MOL

Formula
C17H14Cl2F2N2O3
InChI
InChI=1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24)
InChIKey
MNDBXUUTURYVHR-UHFFFAOYSA-N
CAS Number
CAS 162401-32-3
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
R03DX07
Target and Pathway
Target(s) PDE4 Target Info Modulator [531783]
References
Ref 5317832011 FDA drug approvals. Nat Rev Drug Discov. 2012 Feb 1;11(2):91-4.
Ref 537075Emerging drugs for atopic dermatitis. Expert Opin Emerg Drugs. 2009 Mar;14(1):165-79.
Ref 541997(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6962).
Ref 5317832011 FDA drug approvals. Nat Rev Drug Discov. 2012 Feb 1;11(2):91-4.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.